FOR THERAPISTS & COUNSELORS
We Don’t Replace You. We Make the Work Go Further.
You know your client. Their history, their patterns, the work that took months of trust to get to. We’d never try to replicate that.
What we do is different: a time-limited medical treatment that can open a window of neuroplasticity — and your sessions are often the best place for that window to get used.
WHY THIS MATTERS FOR YOUR WORK
Ketamine Opens a Window. It Doesn’t Decide What Goes In It.
Ketamine acts on the glutamate system rather than serotonin. The downstream effect is increased BDNF and new synaptic connection-building in the prefrontal cortex and hippocampus — regions where chronic depression and trauma produce measurable dendritic loss (Li et al., Science, 2010).
Practically, that means the days after each infusion are a period when the brain is more able to build and hold new patterns than it was the week before.
Here is the part that matters to you: plasticity creates the capacity for change. It doesn’t direct it. New patterns don’t build themselves — what gets practiced during that window is what has the best chance of taking hold. Which is exactly why a client in an active therapeutic relationship tends to get more out of this than a client going through it alone.
Many of our patients describe the same thing: material they had understood intellectually for years suddenly becomes something they can actually act on. That’s your work becoming accessible, not our work replacing it.
IN YOUR SESSIONS
What You May See During the Series
Material surfacing faster
Grief, anger, or memories a client has been circling for months can come up quickly. Pace tends to accelerate. Some clients need you to slow things down as much as move them forward.
Healing isn’t linear
Some clients feel worse before they feel better. That’s not a sign the treatment isn’t working, and it’s exactly why the relationship they already have with you matters so much. We prepare patients for it — but it lands differently coming from someone who knows them.
Capacity to act, not just insight
The most common shift we hear about is behavioral, not cognitive. Clients start doing the thing they already knew they should do. Homework that never got done starts getting done.
Insight without integration
A minority of clients come out with vivid realizations and treat the realization itself as the change. Helping them convert insight into repeated action is where your work is most valuable.
OUR LANE
What We Do — and What We Don’t
We do
- Provide physician-supervised IV infusions with continuous monitoring
- Screen medically and psychiatrically before accepting anyone
- Track PHQ-9 and GAD-7 across the series
- Provide structured psychoeducation on the neurobiology and what to do in the window
- Teach skills-based tools drawn from CBT, DBT, and ACT frameworks
- Encourage clients to keep seeing you throughout
We don’t
- Provide psychotherapy or process trauma content clinically
- Take over psychiatric prescribing — that stays with their prescriber
- Tell clients to reduce or stop therapy
- Position our education as a replacement for what you do
- Offer at-home, oral, or compounded ketamine
- Accept clients we don’t think are appropriate for this treatment
Your therapist works with your story. We teach you how to work with your brain. That’s the line we say to patients, and it’s the line we hold to.
WHAT YOUR CLIENT RECEIVES
🧠 Brain Health Reboot
Included with every series at no additional cost. It covers preparation before the first infusion, the questions that come up at 2am afterward, what to do between sessions, the window of tolerance when emotions run big, and what happens after the sixth infusion.
It is educational, not clinical. Many clients bring what they learn directly into their therapy sessions — and in our experience, that’s when it works best.
If you’d like to see exactly what your client will be working through, the full model is public.
WHO THIS TENDS TO HELP
When to Mention Us
The clients we see do best are often the ones you already know well:
- Someone who has done real work with you and is still stuck at a plateau
- Someone whose depression has not responded to two or more medication trials
- Someone with PTSD who understands their trauma but still cannot regulate around it
- Someone with the insight but not the capacity to act on it
- First responders and veterans, including moral injury presentations
- Someone whose anhedonia is blocking every behavioral intervention you try
Where we’d want to talk first: active psychosis or history of psychotic disorder, current mania, active substance use disorder, pregnancy, uncontrolled cardiovascular disease, or a client in acute crisis who needs a higher level of care than an outpatient series.
We complete our own medical and psychiatric screening on everyone and decline patients we don’t think are appropriate. You are not making a clinical determination by mentioning us — you’re starting a conversation.
How to Refer
No formal referral is needed. Your client can book a free consultation directly, or you can pass along the link.
Want to talk it through first? Call 317-300-4091 and ask for Megan Bonney, PMHNP-BC. We’re glad to answer questions before you say anything to a client.
Staying in the loop: with a signed release, we can coordinate on timing and share how the series is going.
Cost, plainly: IV ketamine is generally not covered by insurance. We accept HSA and FSA, offer financing, and provide first responder and veteran discounts. Pricing is covered at the free consultation, so your client won’t be surprised.
AlphaOmega Wellness • 1777 W Stones Crossing Rd, Suite 140, Greenwood, IN 46143
Serving Greenwood, Indianapolis, Carmel, Fishers, and Central Indiana
Are you a prescriber? See our page for medical providers →
Selected References
- Li N, et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science. 2010. PubMed
- Zarate CA, et al. A randomized trial of an NMDA antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006. PubMed
- Wilkinson ST, et al. The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and IPD meta-analysis. Am J Psychiatry. 2018. NIH / PMC
- Feder A, et al. Efficacy of intravenous ketamine for treatment of chronic PTSD: a randomized clinical trial. JAMA Psychiatry. 2014. PubMed
- Feder A, et al. A randomized controlled trial of repeated ketamine administration for chronic PTSD. Am J Psychiatry. 2021. Am J Psychiatry
IV ketamine is FDA-approved as an anesthetic and is used off-label for mood and trauma-related disorders. Individual results vary.
Medically reviewed by Dee Bonney, MD — Board-Certified Emergency Medicine, Medical Director, AlphaOmega Wellness. Last reviewed: July 2026. Meet our team →